JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)

China · Delayed Price · Currency is CNY

26.75

-0.11 (-0.41%)

At close: Apr 17, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
B Vitamins	1.73B			2.20B	-	-	-
Other Vitamins	328.86M			259.97M	290.98M	202.90M	176.50M
Other Vitamins Growth	-			-10.66%	43.41%	14.96%	-
Fine Chemicals	120.46M			2.15M	-	-	-
Unallocated Other Operating Income	28.00M			-	-	-	-
Vitamin B6	-			-	906.51M	963.78M	1.33B
Vitamin B6 Growth	-			-	-5.94%	-27.38%	-
Vitamin B1	-			-	792.52M	814.13M	1.06B
Vitamin B1 Growth	-			-	-2.65%	-22.86%	-
Biotin	-			-	274.83M	15.10M	12.13M
Biotin Growth	-			-	1719.62%	24.56%	-
Total	2.21B			2.47B	2.26B	2.00B	2.57B
Total Growth	-			8.90%	13.47%	-22.37%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	1.06B			948.63M	948.36M	767.29M	924.57M
China Growth	-			0.03%	23.60%	-17.01%	-
Overseas	1.15B			1.52B	1.32B	1.23B	1.65B
Overseas Growth	-			15.29%	7.15%	-25.39%	-
Total	2.21B			2.47B	2.26B	2.00B	2.57B
Total Growth	-			8.90%	13.47%	-22.37%	-

Source: S&P Global Market Intelligence.